Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals. - Wikidata - awgldk - TriplyDB

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

http://www.wikidata.org/entity/Q37538683

about

Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

P2860

Q52596192-12CCAA6E-B33C-4FF8-A950-A14CE7943F5D

P2860

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.

http://www.wikidata.org/entity/Q37538683

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@en

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@nl

type

label

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@en

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@nl

prefLabel

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@en

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@nl

P1433

Q37538683-2708D178-C2E8-4722-B5ED-A089B77CE190

P1476

Q37538683-4549424D-3EE9-473D-96F3-DBEE0A55ED0D

P2093

Q37538683-42343E79-1A9E-4F99-9638-AC67BFDE2049

Q37538683-6BAB7E05-10D7-42D4-A25F-6BFE9F7E55C7

Q37538683-8F62ECCA-109A-4968-A64B-4CDC7C23E813

Q37538683-DA947CC4-382D-4A07-B965-8E7150E5C749

Q37538683-FB4B8B8C-AA12-40B5-809B-066E826F812D

P2860

Q37538683-0D9EA087-1EA4-4321-A390-3321F73F81F4

Q37538683-17454022-2A40-4142-9357-1C1ADB2C3C13

Q37538683-1A56B445-3FF8-4265-A630-A920B2C547D2

Q37538683-1C4612D3-C31E-4501-9F17-64A0490FF5DE

Q37538683-1C9B903E-4FB8-4FE7-B819-2FB7FBD6AB40

Q37538683-347DC6EA-343E-46BC-9F90-F18B1BF708EF

Q37538683-40FA9A40-33DA-4B63-BF7E-41A6711E2E9C

Q37538683-4849DB55-142A-4E1E-89AB-BA6068AF4150

Q37538683-514DB479-921C-4540-9301-DB8BDD12ABC2

Q37538683-6D9F2257-9C84-48A1-9F5B-504C604A33A8

P31

Q37538683-6FE2DA6A-C02F-4287-88DE-BFD2F5595287

P356

Q37538683-BEA1BADB-4519-4247-AC1E-F229C62DE41F

P407

Q37538683-9F5696B1-E7C8-433E-9955-EEFF56F49801

P433

Q37538683-804F3B56-1FA9-40EC-9818-802D415DC340

P478

Q37538683-D21FECF2-6870-44F9-A19D-E0E1F7D32646

P50

Q37538683-4224D1ED-0F6B-4EE9-BC80-37BF55196D88

Q37538683-5E20EA72-D376-4634-9C44-CF9C10790E8C

Q37538683-79C1CC18-EF99-43F5-8854-F7E9824DFD19

Q37538683-88556E64-85DE-4A13-9C9A-0AD425225DCD

Q37538683-D7B69805-C354-48B4-BB0A-0681D3399882

P577

Q37538683-A6CF071D-A6F5-446C-87E1-C9BC964491DE

P698

Q37538683-B3DCDE05-2C62-4956-AB10-E7C0F5741D5E

P932

Q37538683-2503B196-3F00-411F-92BB-4B88BBBE1A5A

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Population Pharmacokinetics an ...... in HIV-1-Infected Individuals.

@en

P2093

Catalina Barcelo

http://www.w3.org/2001/XMLSchema#string

Cédric Hizrel

http://www.w3.org/2001/XMLSchema#string

Manel Aouri

http://www.w3.org/2001/XMLSchema#string

Margalida Rotger

http://www.w3.org/2001/XMLSchema#string

Thierry Buclin

http://www.w3.org/2001/XMLSchema#string

P2860

dbSNP: the NCBI database of genetic variation

Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Genetic and Clinical Factors Affecting Plasma Clozapine Concentration

Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation.

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms.

P31

scholarly article

P356

10.1128/AAC.00899-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Swiss HIV Cohort Study

Matthias Cavassini

Laurent Arthur Decosterd

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27799217

http://www.w3.org/2001/XMLSchema#string

P932

5192124

http://www.w3.org/2001/XMLSchema#string